investigational

Milestone Pharmaceuticals, a biopharmaceutical company focused on developing innovative therapies for cardiovascular diseases, recently announced that its New Drug Application...

Sanofi, one of the world’s leading pharmaceutical companies, recently announced the discontinuation of the development of tusamitamab ravtansine, a potential...

Arrowhead Pharmaceuticals, a biopharmaceutical company specializing in the development of RNA interference (RNAi) therapeutics, has recently announced that it has...

Inspection Findings at Third-Party Manufacturer Prompt U.S. Food and Drug Administration’s Complete Response Letter for Cosibelimab The U.S. Food and...

In the world of pharmaceuticals and medical research, there are always exciting developments and breakthroughs that capture the attention of...

Kiromic BioPharma, a clinical-stage biotechnology company, has recently announced the administration of the initial dose to the first participant in...

A Preview of Crucial Data Solutions’ Decentralized Clinical Trials in 2024 In recent years, the field of clinical trials has...

Title: Promising Results from ORSERDU® Combination Studies in ER+, HER2- Metastatic Breast Cancer Patients Presented at the 2023 San Antonio...

Title: Promising Results from ORSERDU® Combination Studies in ER+, HER2- Metastatic Breast Cancer Patients Unveiled at the 2023 San Antonio...

Challenges in Accessing Expensive Gene Therapies for Sickle Cell Disease Sickle Cell Disease (SCD) is a genetic disorder that affects...

Frontotemporal dementia (FTD) is a devastating neurodegenerative disorder that primarily affects the frontal and temporal lobes of the brain, leading...

Title: New Drug Shows Potential for Significantly Improving Type 1 Diabetes Management Introduction: Type 1 diabetes is a chronic autoimmune...

A Guide to Managing Phase 1 Clinical Studies in BioPharma Services Phase 1 clinical studies play a crucial role in...

Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products for patients in Greater China and other...